Evidence map›Paper›PMID 40156868›Full record

ArticleNucleic acids research2025

Proxi-RIMS-seq2 applied to native microbiomes uncovers hundreds of known and novel m5C methyltransferase specificities.

Weiwei Yang, Yvette Luyten, Emily Reister, Hayley Mangelson, Zach Sisson, Benjamin Auch, Ivan Liachko, Richard J Roberts, Laurence Ettwiller

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Weiwei YangNew England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, United States.
Yvette LuytenNew England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, United States.
Emily ReisterPhase Genomics, Inc., 1617 8th Ave N, Seattle, WA 98109, United States.
Hayley MangelsonPhase Genomics, Inc., 1617 8th Ave N, Seattle, WA 98109, United States.
Zach SissonPhase Genomics, Inc., 1617 8th Ave N, Seattle, WA 98109, United States.
Benjamin AuchPhase Genomics, Inc., 1617 8th Ave N, Seattle, WA 98109, United States.
Ivan LiachkoPhase Genomics, Inc., 1617 8th Ave N, Seattle, WA 98109, United States.
Richard J RobertsNew England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, United States.ORCID 0000-0002-4348-0169
Laurence EttwillerNew England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, United States.ORCID 0000-0002-3957-6539

Funding

Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligenceR44AI172703 · NIAID · PHASE GENOMICS, INC. · PI LIACHKO, IVAN · 2022 to 2023
$2.0M
Bill & Melinda Gates FoundationNew England Biolabs, Inc.NIAID NIH HHS R44 AI172703NIH HHS R44AI172703
6 · The paper itself

Abstract

Methylation patterns in bacteria can be used to study restriction-modification or other defense systems with novel properties. While m4C and m6A methylation are well characterized mainly through PacBio sequencing, the landscape of m5C methylation is under-characterized. To bridge this gap, we performed RIMS-seq2 (rapid identification of methyltransferase specificity sequencing) on microbiomes composed of resolved assemblies of distinct genomes through proximity ligation. This high-throughput approach enables the identification of m5C methylated motifs and links them to cognate methyltransferases directly on native microbiomes without the need to isolate bacterial strains. Methylation patterns can also be identified on bacteriophage DNA and compared with host DNA, strengthening evidence for phage-host interactions. Applied to three different microbiomes, the method unveiled over 1900 motifs that were deposited in REBASE. The motifs include a novel eight-base recognition site (CATm5CGATG) that was experimentally validated by characterizing its cognate methyltransferase. Our findings suggest that microbiomes harbor arrays of untapped m5C methyltransferase specificities, providing insights into bacterial biology and biotechnological applications.

Indexed as

BacteriaMethyltransferasesMicrobiotaBacteriophagesDNA MethylationHigh-Throughput Nucleotide SequencingSubstrate SpecificityMethyltransferases

Identifiers

PMID40156868
PMCPMC11954522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.